Table 3.
Summary of cost effectiveness analyses
| Author (year) | Model | Perspective | Time Horizon | Currency Year | Discount Rate | Incremental Cost | Incremental Effect | Cost effectiveness Estimate | % GDP per capita | Uncertainty | Sensitivity Analysis |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Blakely et al. 2014 | Markov model BODE protocol |
Health system | 110 years | 2011 NZ$ | 3% | *NZ$ 4.65 million NZ$ 2.773 million NZ$ 3.784 million |
*266 QALYs 348 QALYs 382 QALYs |
$18,800 per QALY gained $34,700 per QALY gained $122,500 per QALY gained |
38.2% 71.4% 252.1% |
Yes | Yes |
| Wilson et al. 2020 | Markov model | Payer | 20 years | 2016 US$ | 3% | $158,048 | 1.80 LYS | US$$79,022 per LYS | 136.2% | no | Yes |
% GDP per capita represents the percentage of the per capita GDP of the ICER in the currency year for the study. World bank values for per capita GDP in reference years were used with rates obtained from OECD exchange rates database.